The store will not work correctly when cookies are disabled.
6-fluoro-3-(2-methoxyphenylselanyl)-2-phenylimidazo[1,2-a]pyridine
ID: ALA4514249
PubChem CID: 155539305
Max Phase: Preclinical
Molecular Formula: C20H15FN2OSe
Molecular Weight: 397.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1[Se]c1c(-c2ccccc2)nc2ccc(F)cn12
Standard InChI: InChI=1S/C20H15FN2OSe/c1-24-16-9-5-6-10-17(16)25-20-19(14-7-3-2-4-8-14)22-18-12-11-15(21)13-23(18)20/h2-13H,1H3
Standard InChI Key: NVWOJAYVNVNWCW-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
27.7291 -2.9835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7279 -3.8109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4428 -4.2238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4409 -2.5707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1563 -2.9798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1612 -3.8063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9487 -4.0571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4307 -3.3856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9409 -2.7199 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2537 -3.3803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6699 -4.0939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4941 -4.0894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9032 -3.3720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4821 -2.6576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6592 -2.6656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0131 -4.2228 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.2083 -4.8402 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
29.6597 -5.4566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8534 -5.2873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3051 -5.9027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5645 -6.6869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3772 -6.8520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9219 -6.2352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7306 -6.3985 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.9935 -7.1805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 10 1 0
2 16 1 0
7 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
23 24 1 0
24 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 397.31 | Molecular Weight (Monoisotopic): 398.0334 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Chitti S, Singireddi S, Santosh Kumar Reddy P, Trivedi P, Bobde Y, Kumar C, Rangan K, Ghosh B, Sekhar KVGC.. (2019) Design, synthesis and biological evaluation of 2-(3,4-dimethoxyphenyl)-6 (1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyridine analogues as antiproliferative agents., 29 (18): [PMID:31420269] [10.1016/j.bmcl.2019.08.013] |